Parts 1 and 2 The Investigator will select 1 eye per patient to be the study eye. During the trial, if there is an underlying inflammatory condition in the fellow eye, topical steroids or periocular or intravitreal steroid injection could be used. If both eyes are eligible for the study, the eligible eye with the shorter duration of disease (macular edema) will be used as the study eye.